 |
The Journal of Neuroscience, June 29, 2005, 25(26):6119-6126; doi:10.1523/JNEUROSCI.0285-05.2005
Previous Article | Next Article 
Cellular/Molecular
Epac Mediates a cAMP-to-PKC Signaling in Inflammatory Pain: An Isolectin B4(+) Neuron-Specific Mechanism
Tim B. Hucho,
Olayinka A. Dina, and
Jon D. Levine
National Institutes of Health Pain Center, University of California, San Francisco, San Francisco, California 94143
The isoform of protein kinase C (PKC ) has emerged as a critical second messenger in sensitization toward mechanical stimulation in models of neuropathic (diabetes, alcoholism, and cancer therapy) as well as acute and chronic inflammatory pain. Signaling pathways leading to activation of PKC remain unknown. Recent results indicate signaling from cAMP to PKC. A mechanism connecting cAMP and PKC, two ubiquitous, commonly considered separate pathways, remains elusive. We found that, in cultured DRG neurons, signaling from cAMP to PKC is not mediated by PKA but by the recently identified cAMP-activated guanine exchange factor Epac. Epac, in turn, was upstream of phospholipase C (PLC) and PLD, both of which were necessary for translocation and activation of PKC . This signaling pathway was specific to isolectin B4-positive [IB4(+)] nociceptors. Also, in a behavioral model, cAMP produced mechanical hyperalgesia (tenderness) through Epac, PLC/PLD, and PKC . By delineating this signaling pathway, we provide a mechanism for cAMP-to-PKC signaling, give proof of principle that the mitogen-activated protein kinase pathway-activating protein Epac also stimulates PKC, describe the first physiological function unique for the IB4(+) subpopulation of sensory neurons, and find proof of principle that G-protein-coupled receptors can activate PKC not only through the G-proteins q and  but also through s.
Key words: nociception; inflammation; intracellular signaling; -adrenergic receptor; cAMP; PKC; Epac; PLD; IB4
Received Jan 20, 2005;
revised May 8, 2005;
accepted May 9, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
L. S. Stone and D. C. Molliver
In Search of Analgesia: Emerging Poles of GPCRs in Pain
Mol. Interv.,
October 1, 2009;
9(5):
234 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Borland, R. J. Bird, T. M. Palmer, and S. J. Yarwood
Activation of Protein Kinase C{alpha} by EPAC1 Is Required for the ERK- and CCAAT/Enhancer-binding Protein {beta}-dependent Induction of the SOCS-3 Gene by Cyclic AMP in COS1 Cells
J. Biol. Chem.,
June 26, 2009;
284(26):
17391 - 17403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ster, F. de Bock, F. Bertaso, K. Abitbol, H. Daniel, J. Bockaert, and L. Fagni
Epac mediates PACAP-dependent long-term depression in the hippocampus
J. Physiol.,
January 1, 2009;
587(1):
101 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gong, Z. Li, M. Xu, J. Du, Z. Lv, and Y. Zhang
A Novel Protein Kinase A-independent, {beta}-Arrestin-1-dependent Signaling Pathway for p38 Mitogen-activated Protein Kinase Activation by {beta}2-Adrenergic Receptors
J. Biol. Chem.,
October 24, 2008;
283(43):
29028 - 29036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ouyang, L. Zhang, J. J. Zhu, F. Schwede, and S. A. Thomas
Epac signaling is required for hippocampus-dependent memory retrieval
PNAS,
August 19, 2008;
105(33):
11993 - 11997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gekel and E. Neher
Application of an Epac Activator Enhances Neurotransmitter Release at Excitatory Central Synapses
J. Neurosci.,
August 6, 2008;
28(32):
7991 - 8002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Schnizler, L. P. Shutov, M. J. Van Kanegan, M. A. Merrill, B. Nichols, G. S. McKnight, S. Strack, J. W. Hell, and Y. M. Usachev
Protein Kinase A Anchoring via AKAP150 Is Essential for TRPV1 Modulation by Forskolin and Prostaglandin E2 in Mouse Sensory Neurons
J. Neurosci.,
May 7, 2008;
28(19):
4904 - 4917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, C.-L. Cang, Y. Kawasaki, L.-L. Liang, Y.-Q. Zhang, R.-R. Ji, and Z.-Q. Zhao
Neurokinin-1 Receptor Enhances TRPV1 Activity in Primary Sensory Neurons via PKC{varepsilon}: A Novel Pathway for Heat Hyperalgesia
J. Neurosci.,
October 31, 2007;
27(44):
12067 - 12077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wang, Y. Gu, G.-W. Li, and L.-Y. M. Huang
A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2-induced potentiation of P2X3 receptor currents in inflamed rats
J. Physiol.,
October 1, 2007;
584(1):
191 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ster, F. De Bock, N. C. Guerineau, A. Janossy, S. Barrere-Lemaire, J. L. Bos, J. Bockaert, and L. Fagni
Exchange protein activated by cAMP (Epac) mediates cAMP activation of p38 MAPK and modulation of Ca2+-dependent K+ channels in cerebellar neurons
PNAS,
February 13, 2007;
104(7):
2519 - 2524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Nicol and M. R. Vasko
Unraveling the Story of NGF-mediated Sensitization of Nociceptive Sensory Neurons: ON or OFF the Trks?
Mol. Interv.,
February 1, 2007;
7(1):
26 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Choi, S. D. Dib-Hajj, and S. G. Waxman
Differential Slow Inactivation and Use-Dependent Inhibition of Nav1.8 Channels Contribute to Distinct Firing Properties in IB4+ and IB4- DRG Neurons
J Neurophysiol,
February 1, 2007;
97(2):
1258 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Amaya, H. Wang, M. Costigan, A. J. Allchorne, J. P. Hatcher, J. Egerton, T. Stean, V. Morisset, D. Grose, M. J. Gunthorpe, et al.
The Voltage-Gated Sodium Channel Nav1.9 Is an Effector of Peripheral Inflammatory Pain Hypersensitivity
J. Neurosci.,
December 13, 2006;
26(50):
12852 - 12860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Holz, G. Kang, M. Harbeck, M. W. Roe, and O. G. Chepurny
Cell physiology of cAMP sensor Epac
J. Physiol.,
November 15, 2006;
577(1):
5 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Amadesi, G. S. Cottrell, L. Divino, K. Chapman, E. F. Grady, F. Bautista, R. Karanjia, C. Barajas-Lopez, S. Vanner, N. Vergnolle, et al.
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase C{varepsilon}- and A-dependent mechanisms in rats and mice
J. Physiol.,
September 1, 2006;
575(2):
555 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Alessandri-Haber, O. A. Dina, E. K. Joseph, D. Reichling, and J. D. Levine
A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators.
J. Neurosci.,
April 5, 2006;
26(14):
3864 - 3874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Lindfors, V. Voikar, J. Rossi, and M. S. Airaksinen
Deficient Nonpeptidergic Epidermis Innervation and Reduced Inflammatory Pain in Glial Cell Line-Derived Neurotrophic Factor Family Receptor {alpha}2 Knock-Out Mice
J. Neurosci.,
February 15, 2006;
26(7):
1953 - 1960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Griffin
An Epac-Dependent Pain Pathway
J. Neurosci.,
September 7, 2005;
25(36):
8113 - 8114.
[Full Text]
[PDF]
|
 |
|
|

|